A spin labelling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes (Q44378545)

2 December 2017

A spin labelling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes (English)

1 reference

2 December 2017

Ruza Frkanec

1

1 reference

2 December 2017

Vesna Noethig-Laslo

2

1 reference

2 December 2017

Branka Vranesić

3

1 reference

2 December 2017

Krunoslav Mirosavljević

4

1 reference

2 December 2017

Jelka Tomasić

5

1 reference

2 December 2017

1 April 2003

1 reference

Biochimica et Biophysica Acta

2 December 2017

1 reference

2 December 2017

1611

1 reference

2 December 2017

1-2

1 reference

2 December 2017

187-196

1 reference

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Synthetic immunoadjuvants: application to non-specific host stimulation and potentiation of vaccine immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Synthesis of phthalimido-desmuramylpeptide analogues as potential immunomodulating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Comparative susceptibility of a peptidoglycan monomer from Brevibacterium divaricatum and its anhydromuramyl analogue to hydrolysis with N-acetylmuramyl-L-alanine amidase. Isolation and characterization of anhydromuramyl-peptidoglycan monomer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Synthesis and Antiviral Activity of Novel Adamantylpeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Influence of adjuvant-active peptidoglycan monomer on specific T cell responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

The metabolic fate of 14C-labeled peptidoglycan monomer in mice. I. Identification of the monomer and the corresponding pentapeptide in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Partial purification and characterization of N-acetylmuramyl-L-alanine amidase from human and mouse serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Relationship of metabolism and immunostimulating activity of peptidoglycan monomer in mice after three different routes of administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Adjuvant activity of peptidoglycan monomer and its metabolic products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Liposomes and ISCOMS as vaccine formulations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Trends and developments in liposome drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Interaction of immunologically-active lipopeptides with membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Influence of cholesterol on liposome fluidity by EPR. Relationship with percutaneous absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

EPR study of spermine interaction with multilamellar phosphatidylcholine liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Protective effect of glycine against liposome membrane-perturbation and lysis induced by chlorpromazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Reversed-phase high-performance liquid chromatographic method for the determination of peptidoglycan monomers and structurally related peptides and adamantyltripeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Molecular motion in spin-labeled phospholipids and membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Liposome-encapsulated muramyl tripeptide up-regulates monocyte chemotactic and activating factor gene expression in human monocytes at the transcriptional and post-transcriptional levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Stimulation of nonspecific immunity, haemopoiesis and protection of mice against radiation injury by 1-adamantylamide-L-alanyl-D-isoglutamine incorporated in liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Liposomal muramyl tripeptide (CGP 19835A lipid) therapy for resectable melanoma in patients who were at high risk for relapse: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Encapsulation of immunoadjuvant [14C]peptidoglycan monomer into liposomes. Effect on metabolism and immune response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

Chemoimmunotherapy of murine liver metastases with 5-fluorouracil in combination with liposome-encapsulated muramyl dipeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2803%2900054-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0005-2736(03)00054-3

1 reference

2 December 2017

1 reference